Med-Tech Innovation July 18, 2024
Allergic and autoimmune diseases are regarded as key global health challenges.1,2 The prevalence of allergic diseases is rapidly increasing across the world, and estimates suggest that as many as one in ten people may suffer from one or more allergic diseases, ranging from mild rhinitis to severe anaphylaxis or asthma.1 Autoimmune diseases are estimated to affect as many as one in ten individuals, with more than 100 different disease types identified to date.3,4
As a leader in in-vitro diagnostics, our ambition at Thermo Fisher Scientific is to enable millions of people around the world to receive the right diagnosis for their allergic or autoimmune diseases. Here we discuss some of the challenges in this field and how we are working...
Today's Sponsors
Today's Sponsor